Millennium Management Portfolio holdings
Millennium Management is a multistrategy hedge fund firm, started in 1989 by Israel Englander along with Ronald Shear, an acquaintance from the American Stock Exchange who left after six months. Englander remains its principal. It works as a platform: many separate investment teams, each with a portfolio manager given money to trade in a variety of strategies. Its teams research and pick individual companies, run computer-driven strategies, and trade fixed income, commodities and credit. In 2018 it launched a joint venture with WorldQuant, a computer-driven investment firm. Its clients include state and local government bodies and sovereign wealth funds.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.07B |
| 2 |
SpaceX
SPCX
|
+$2.99B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$1.11B |
| 4 |
Microsoft
MSFT
|
+$584M |
| 5 |
Bloom Energy
BE
|
+$547M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.65B |
| 2 |
Marvell Technology
MRVL
|
+$1.16B |
| 3 |
Apple
AAPL
|
+$1.12B |
| 4 |
Sandisk
SNDK
|
+$1.11B |
| 5 |
Micron Technology
MU
|
+$816M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.34% |
| 2 | Technology | 9.51% |
| 3 | Industrials | 7.56% |
| 4 | Financials | 5.78% |
| 5 | Healthcare | 5.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2726
Kiniksa Pharmaceuticals
KNSA
$6.94B
| $5.97M | ﹤0.01% |
93,364
-471,056
| -83% | -$24.4M |
2019 Q4
26 quarters
|
|
2727
Sizzle Acquisition Corp II
SZZL
$330M
| $5.97M | ﹤0.01% |
576,020
-149,480
| -21% | -$1.54M |
2025 Q2
4 quarters
|
|
2728
Blend Labs
BLND
$270M
| $5.97M | ﹤0.01% |
3,489,742
+3,270,822
| +1,494% | +$5.22M |
2022 Q4
14 quarters
|
|
2729
Pacira BioSciences
PCRX
$1.45B
| $5.97M | ﹤0.01% |
235,163
+178,132
| +312% | +$4.21M |
2024 Q3
7 quarters
|
|
2730
Art Technology Acquisition Corp
ARTC
$349M
| $5.96M | ﹤0.01% |
+600,000
| New | +$5.93M |
2026 Q2
0 quarters
|
|
2731
Oppenheimer Holdings
OPY
$944M
| $5.95M | ﹤0.01% |
56,398
-10,935
| -16% | -$1.11M |
2023 Q1
13 quarters
|
|
2732
DiaMedica Therapeutics
DMAC
$487M
| $5.95M | ﹤0.01% |
845,309
-90,283
| -10% | -$555K |
2025 Q3
3 quarters
|
|
2733
Paloma Acquisition Corp I
PALO
| $5.95M | ﹤0.01% |
+600,000
| New | +$5.93M |
2026 Q2
0 quarters
|
|
2734
SI-BONE Inc
SIBN
$1.09B
| $5.95M | ﹤0.01% |
364,286
-5,017
| -1% | -$71.7K |
2025 Q1
5 quarters
|
|
2735
CALL
Fifth Third Bancorp
FITB
$48.5B
| $5.94M | ﹤0.01% |
105,300
+46,800
| +80% | +$2.37M |
2024 Q3
7 quarters
|
|
2736
CALL
Campbell Soup
CPB
$6.99B
| $5.91M | ﹤0.01% |
265,500
-175,700
| -40% | -$3.71M |
2023 Q4
10 quarters
|
|
2737
PUT
Huntington Ingalls Industries
HII
$11.4B
| $5.91M | ﹤0.01% |
21,100
+10,500
| +99% | +$3.51M |
2025 Q1
5 quarters
|
|
2738
Blue Water Acquisition Corp III
BLUW
$336M
| $5.89M | ﹤0.01% |
570,300
| – | – |
2025 Q3
3 quarters
|
|
2739
CALL
Cognizant
CTSH
$29.7B
| $5.89M | ﹤0.01% |
152,000
-105,900
| -41% | -$5.58M |
2022 Q2
16 quarters
|
|
2740
PUT
VeriSign
VRSN
$28B
| $5.89M | ﹤0.01% |
23,400
+8,100
| +53% | +$2.25M |
2025 Q1
5 quarters
|
|
2741
CALL
Kimberly-Clark
KMB
$36.7B
| $5.88M | ﹤0.01% |
53,600
+20,100
| +60% | +$1.99M |
2021 Q3
19 quarters
|
|
2742
Atlanta Braves Holdings Series A
BATRA
$3.53B
| $5.88M | ﹤0.01% |
104,438
+821
| +0.8% | +$43.8K |
2023 Q3
11 quarters
|
|
2743
Bristow Group
VTOL
$1.09B
| $5.88M | ﹤0.01% |
142,241
+23,117
| +19% | +$1.04M |
2024 Q3
7 quarters
|
|
2744
PUT
Elastic
ESTC
$8.84B
| $5.87M | ﹤0.01% |
+103,000
| New | +$5.52M |
2026 Q2
0 quarters
|
|
2745
Postal Realty Trust
PSTL
$654M
| $5.86M | ﹤0.01% |
237,914
-87,136
| -27% | -$1.94M |
2023 Q3
11 quarters
|
|
2746
CALL
PTC
PTC
$21.1B
| $5.85M | ﹤0.01% |
+51,500
| New | +$6.95M |
2026 Q2
0 quarters
|
|
2747
PUT
Rivian
RIVN
$19.4B
| $5.85M | ﹤0.01% |
337,100
-639,400
| -65% | -$10M |
2022 Q2
16 quarters
|
|
2748
Coastal Financial
CCB
$661M
| $5.84M | ﹤0.01% |
75,301
-25,884
| -26% | -$1.94M |
2026 Q1
1 quarter
|
|
2749
State Street SPDR S&P Biotech ETF
XBI
$10.1B
| $5.84M | ﹤0.01% |
36,882
+1,964
| +6% | +$266K |
2025 Q1
5 quarters
|
|
2750
Portillo's
PTLO
$509M
| $5.83M | ﹤0.01% |
1,229,588
+608,172
| +98% | +$2.94M |
2025 Q4
2 quarters
|
|
Similar funds
Millennium Management's Q2 2026 Portfolio in Review
As of Q2 2026, Millennium Management held 6,628 positions worth $276B, up 15% from $240B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management's Q2 2026 filing shows 986 new, 2,006 increased, 2,341 reduced and 833 closed positions. Its largest new stake was SpaceX: 17,604,863 shares worth $2.98B. The largest sale was State Street SPDR Portfolio S&P 500 ETF, an estimated $1.65B.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, up from 54% a quarter earlier, followed by Technology and Industrials.
- Millennium Management's largest Q2 2026 buy was SpaceX: 17,604,863 shares worth $2.98B.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $3.07B increase.
- Millennium Management's biggest Q2 2026 reduction was Marvell Technology, cutting an estimated $1.16B.
- Millennium Management fully exited State Street SPDR Portfolio S&P 500 ETF in Q2 2026, selling an estimated $1.65B.
- Millennium Management's ten largest holdings make up 18% of its $276B portfolio in Q2 2026.
- Millennium Management opened 986 new positions and closed 833 in Q2 2026.
- Millennium Management's portfolio value rose 15% quarter-over-quarter to $276B.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.